Clinical Trial Update: Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC) [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 trial evaluating chemotherapy plus Endostar for advanced or recurrent non-small cell lung cancer, sponsored by Sim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Simcere Pharmaceutical Co., Ltd | Conditions: Advanced NSCLC, Recurrent NSCLC | Phase 4 | Status: UNKNOWN